Prevalence of endocrine complications in beta-thalassaemia major in the Islamic Republic of Iran
- PMID: 15562733
Prevalence of endocrine complications in beta-thalassaemia major in the Islamic Republic of Iran
Abstract
To identify the prevalence of endocrine dysfunction in Iranians with beta-thalassaemia, we assessed thyroid, parathyroid, pancreatic and adrenal function in 150 beta-thalassaemic patients aged 10-22 years at the Paediatrics Unit, Shiraz University of Medical Sciences. Primary hypothyroidism was found in 6.0% of patients (mean age: 14.6 +/- 1.9 years), hypoparathyroidism in 7.3% (14.5 +/- 3.2 years), type 1 diabetes mellitus in 7.3% (13.9 +/- 2.8 years) and adrenal insufficiency in 1 patient. The relatively high frequency of endocrine dysfunction found in our study may be a result of poor disease control and management in early life when irreversible tissue damage occurs due to iron overload. These findings reinforce the importance of regular follow-up of patients with beta-thalassaemia major for early detection and management of associated complications.
Similar articles
-
Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre.Pediatr Endocrinol Rev. 2008 Oct;6 Suppl 1:158-69. Pediatr Endocrinol Rev. 2008. PMID: 19337172
-
Endocrine complications in patients with Thalassaemia Major.Pediatr Endocrinol Rev. 2007 Dec;5(2):642-8. Pediatr Endocrinol Rev. 2007. PMID: 18084158 Review.
-
Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF).Pediatr Endocrinol Rev. 2004 Dec;2 Suppl 2:249-55. Pediatr Endocrinol Rev. 2004. PMID: 16462705
-
Endocrinopathies in patients with thalassemias.Saudi Med J. 2004 Oct;25(10):1347-51. Saudi Med J. 2004. PMID: 15494799 Review.
-
Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major.Ann Hematol. 2012 Jul;91(7):1107-14. doi: 10.1007/s00277-012-1412-7. Epub 2012 Jan 28. Ann Hematol. 2012. PMID: 22281991
Cited by
-
Endocrine and bone complications in β-thalassemia intermedia: current understanding and treatment.Biomed Res Int. 2015;2015:813098. doi: 10.1155/2015/813098. Epub 2015 Mar 5. Biomed Res Int. 2015. PMID: 25834825 Free PMC article. Review.
-
Evaluation of serum levels in T3, T4 and TSH in beta-thalassemic patients referred to the Abuzar hospital in Ahwaz.Electron Physician. 2016 Jul 25;8(7):2620-4. doi: 10.19082/2620. eCollection 2016 Jul. Electron Physician. 2016. PMID: 27648188 Free PMC article.
-
Thyroid Function in Chronically Transfused Children with Beta Thalassemia Major: A Cross-Sectional Hospital Based Study.Int J Pediatr. 2018 Sep 16;2018:9071213. doi: 10.1155/2018/9071213. eCollection 2018. Int J Pediatr. 2018. PMID: 30305822 Free PMC article.
-
Hypothyroidism and Hypoparathyroidism in Thalassemia Major Patients: A Study in Sistan and Baluchestan Province, Iran.Int J Endocrinol Metab. 2018 Feb 10;16(2):e13228. doi: 10.5812/ijem.13228. eCollection 2018 Apr. Int J Endocrinol Metab. 2018. PMID: 29868126 Free PMC article.
-
Detection of endocrine disorders in young children with multi-transfused thalassemia major.Ital J Pediatr. 2021 Jul 31;47(1):165. doi: 10.1186/s13052-021-01116-2. Ital J Pediatr. 2021. PMID: 34332621 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical